Drug profile · INN
pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates)
SYNFLORIX
pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates) (SYNFLORIX) is an FDA-listed pharmaceutical active ingredient.
Drug details — pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.78
Quick answer
pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates) (SYNFLORIX) is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates)?
pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates) (SYNFLORIX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates)?
SYNFLORIX is a marketed brand name for pneumococcal 10-valent conjugate vaccine adsorbed (non-typeable haemophilus influenzae [nthi] protein d, diphtheria or tetanus toxoid conjugates). Check FDA Drugs@FDA for the current US label holder and prescribing information.